Cargando…

Correction to: Comparative Effectiveness of Pegcetacoplan Versus Ravulizumab and Eculizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria: A Matching-Adjusted Indirect Comparison

Detalles Bibliográficos
Autores principales: Wong, Raymond, Fishman, Jesse, Wilson, Koo, Yeh, Michael, Al-Adhami, Mohammed, Zion, Abigail, Yee, Christopher W., Huynh, Lynn, Duh, Mei Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611589/
https://www.ncbi.nlm.nih.gov/pubmed/37789229
http://dx.doi.org/10.1007/s12325-023-02640-9
_version_ 1785128523035312128
author Wong, Raymond
Fishman, Jesse
Wilson, Koo
Yeh, Michael
Al-Adhami, Mohammed
Zion, Abigail
Yee, Christopher W.
Huynh, Lynn
Duh, Mei Sheng
author_facet Wong, Raymond
Fishman, Jesse
Wilson, Koo
Yeh, Michael
Al-Adhami, Mohammed
Zion, Abigail
Yee, Christopher W.
Huynh, Lynn
Duh, Mei Sheng
author_sort Wong, Raymond
collection PubMed
description
format Online
Article
Text
id pubmed-10611589
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-106115892023-10-29 Correction to: Comparative Effectiveness of Pegcetacoplan Versus Ravulizumab and Eculizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria: A Matching-Adjusted Indirect Comparison Wong, Raymond Fishman, Jesse Wilson, Koo Yeh, Michael Al-Adhami, Mohammed Zion, Abigail Yee, Christopher W. Huynh, Lynn Duh, Mei Sheng Adv Ther Correction Springer Healthcare 2023-10-04 2023 /pmc/articles/PMC10611589/ /pubmed/37789229 http://dx.doi.org/10.1007/s12325-023-02640-9 Text en © Springer Healthcare Ltd., part of Springer Nature 2023 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Correction
Wong, Raymond
Fishman, Jesse
Wilson, Koo
Yeh, Michael
Al-Adhami, Mohammed
Zion, Abigail
Yee, Christopher W.
Huynh, Lynn
Duh, Mei Sheng
Correction to: Comparative Effectiveness of Pegcetacoplan Versus Ravulizumab and Eculizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria: A Matching-Adjusted Indirect Comparison
title Correction to: Comparative Effectiveness of Pegcetacoplan Versus Ravulizumab and Eculizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria: A Matching-Adjusted Indirect Comparison
title_full Correction to: Comparative Effectiveness of Pegcetacoplan Versus Ravulizumab and Eculizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria: A Matching-Adjusted Indirect Comparison
title_fullStr Correction to: Comparative Effectiveness of Pegcetacoplan Versus Ravulizumab and Eculizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria: A Matching-Adjusted Indirect Comparison
title_full_unstemmed Correction to: Comparative Effectiveness of Pegcetacoplan Versus Ravulizumab and Eculizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria: A Matching-Adjusted Indirect Comparison
title_short Correction to: Comparative Effectiveness of Pegcetacoplan Versus Ravulizumab and Eculizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria: A Matching-Adjusted Indirect Comparison
title_sort correction to: comparative effectiveness of pegcetacoplan versus ravulizumab and eculizumab in complement inhibitor-naïve patients with paroxysmal nocturnal hemoglobinuria: a matching-adjusted indirect comparison
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611589/
https://www.ncbi.nlm.nih.gov/pubmed/37789229
http://dx.doi.org/10.1007/s12325-023-02640-9
work_keys_str_mv AT wongraymond correctiontocomparativeeffectivenessofpegcetacoplanversusravulizumabandeculizumabincomplementinhibitornaivepatientswithparoxysmalnocturnalhemoglobinuriaamatchingadjustedindirectcomparison
AT fishmanjesse correctiontocomparativeeffectivenessofpegcetacoplanversusravulizumabandeculizumabincomplementinhibitornaivepatientswithparoxysmalnocturnalhemoglobinuriaamatchingadjustedindirectcomparison
AT wilsonkoo correctiontocomparativeeffectivenessofpegcetacoplanversusravulizumabandeculizumabincomplementinhibitornaivepatientswithparoxysmalnocturnalhemoglobinuriaamatchingadjustedindirectcomparison
AT yehmichael correctiontocomparativeeffectivenessofpegcetacoplanversusravulizumabandeculizumabincomplementinhibitornaivepatientswithparoxysmalnocturnalhemoglobinuriaamatchingadjustedindirectcomparison
AT aladhamimohammed correctiontocomparativeeffectivenessofpegcetacoplanversusravulizumabandeculizumabincomplementinhibitornaivepatientswithparoxysmalnocturnalhemoglobinuriaamatchingadjustedindirectcomparison
AT zionabigail correctiontocomparativeeffectivenessofpegcetacoplanversusravulizumabandeculizumabincomplementinhibitornaivepatientswithparoxysmalnocturnalhemoglobinuriaamatchingadjustedindirectcomparison
AT yeechristopherw correctiontocomparativeeffectivenessofpegcetacoplanversusravulizumabandeculizumabincomplementinhibitornaivepatientswithparoxysmalnocturnalhemoglobinuriaamatchingadjustedindirectcomparison
AT huynhlynn correctiontocomparativeeffectivenessofpegcetacoplanversusravulizumabandeculizumabincomplementinhibitornaivepatientswithparoxysmalnocturnalhemoglobinuriaamatchingadjustedindirectcomparison
AT duhmeisheng correctiontocomparativeeffectivenessofpegcetacoplanversusravulizumabandeculizumabincomplementinhibitornaivepatientswithparoxysmalnocturnalhemoglobinuriaamatchingadjustedindirectcomparison